Hospira
NYSE:HSPHospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Rubicon Minerals
TSE:RMXRubicon Minerals Corporation engages in the exploration and development of gold properties in Canada and the United States. The company holds a 100% interest in Phoenix Gold project located in the Red Lake gold district in northwestern Ontario, Canada. It also holds interests in approximately 285 square kilometers of exploration ground in the Red Lake gold district; and approximately 900 square kilometers of mineral property interests in the Long Canyon gold district in the Nevada-Utah border. The company was founded in 1996 and is headquartered in Toronto, Canada.